PPI Treatment Interruption Has Dangerous Consequences
February 23, 2012
Patients with Zollinger-Ellison syndrome (ZES) are treated by PPIs to protect them from severe and potentially lethal peptic complications related to massive gastric acid hypersecretion. In a study appearing in Clinical Gastroenterology and Hepatology, doctors warned that PPI treatment interruption has dangerous consequences, and PPI therapy always should be maintained in patients known or suspected of ZES. Diagnostic evaluations should be performed under PPI protection.
Clinical Gastroenterology and Hepatology 2012: 10(2): 199-202
0 out of 0 users found this page helpful.
Was this page helpful?
Only current members of the American Gastroenterological Association may post comments to this page.
Login To Comment
